HLA Diagnostics - HLA Antibody Screening and Identification (445)

Samples:

5 samples of 1 mL

Sample properties:

Liquid serum

Requirement for EQAS/PT according to Rili-BÄK

Certificate Validity: not applicable

Not subject to Rili-BÄK

Parameters:

HLA antibody determination: HLA antibody screening by complement-dependent cytotoxicity test (CDC) and/or with solid phase immunoassays, antibody identification by CDC and/or antibody identification by solid phase immunoassays (ELISA, Luminex), solid phase complement binding assays (C1q, C3d, C4d etc.).

Certificate Validity: 12 months

Shipping Information:

Shipping not cooled

Safety Information:

Process as patient sample material

Dates:

Registration deadline:

Sample shipment:

Closing Date:

Feb. (1)	Aug. (4)
13.11.2026	14.05.2027
11.01.2027	12.07.2027
19.02.2027	20.08.2027

EQAS/PT Experts:

Dr.-Ing. Nils Lachmann

Charité-Universitätsmedizin Berlin, ZTB-Zentrum für Transfusionsmedizin

und Zelltherapie Berlin gGmbH, Gewebetypisierung am Campus Virchow-Klinikum

Augustenburger Platz 1

13353 Berlin

+49 30 450 665 098

nils.lachmann@instand-ringversuch.de

Sükran Zaralioglu

Charité-Universitätsmedizin Berlin, ZTB-Zentrum für Transfusionsmedizin

und Zelltherapie Berlin gGmbH, Gewebetypisierung am Campus Virchow-Klinikum

Augustenburger Platz 1

13353 Berlin

+49 30 450 665 098

suekran.zaralioglu@charite.de

back